These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 25903215)

  • 1. A pilot study of ezetimibe vs. atorvastatin for improving peripheral microvascular endothelial function in stable patients with type 2 diabetes mellitus.
    Sugiyama S; Jinnouchi H; Hieshima K; Kurinami N; Suzuki T; Miyamoto F; Kajiwara K; Matsui K; Jinnouchi T
    Lipids Health Dis; 2015 Apr; 14():37. PubMed ID: 25903215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atorvastatin 10 mg plus ezetimibe 10mg compared with atorvastatin 20 mg: impact on the lipid profile in Japanese patients with abnormal glucose tolerance and coronary artery disease.
    Uemura Y; Watarai M; Ishii H; Koyasu M; Takemoto K; Yoshikawa D; Shibata R; Matsubara T; Murohara T
    J Cardiol; 2012 Jan; 59(1):50-6. PubMed ID: 22100058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in action of atorvastatin and ezetimibe in lowering low-density lipoprotein cholesterol and effect on endothelial function: randomized controlled trial.
    Matsue Y; Matsumura A; Suzuki M; Hashimoto Y; Yoshida M
    Circ J; 2013; 77(7):1791-8. PubMed ID: 23603824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ezetimibe/simvastatin vs atorvastatin in patients with type 2 diabetes mellitus and hypercholesterolemia: the VYTAL study.
    Goldberg RB; Guyton JR; Mazzone T; Weinstock RS; Polis A; Edwards P; Tomassini JE; Tershakovec AM
    Mayo Clin Proc; 2006 Dec; 81(12):1579-88. PubMed ID: 17165637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ezetimibe/simvastatin 10/20 mg vs. atorvastatin 20 mg on apolipoprotein B/apolipoprotein A1 in Korean patients with type 2 diabetes mellitus: results of a randomized controlled trial.
    Lee JH; Kang HJ; Kim HS; Sohn DW; Oh BH; Park YB
    Am J Cardiovasc Drugs; 2013 Oct; 13(5):343-51. PubMed ID: 23728830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
    Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E;
    Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Combination Therapy of Ezetimibe and Atorvastatin on Remnant Lipoprotein Versus Double Atorvastatin Dose in Egyptian Diabetic Patients.
    El-Tamalawy MM; Ibrahim OM; Hassan TM; El-Barbari AA
    J Clin Pharmacol; 2018 Jan; 58(1):34-41. PubMed ID: 28858387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome.
    Robinson JG; Ballantyne CM; Hsueh WA; Rosen JB; Lin J; Shah AK; Tomassini JE; Lowe RS; Tershakovec AM
    J Clin Lipidol; 2013; 7(4):292-303. PubMed ID: 23890516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Ezetimibe in Combination with Atorvastatin for Acute Coronary Syndrome Patients Accompanied with Type 2 Diabetes: A Single-Center, Non-randomized Cohort Study.
    Huang Z; Li Q; Ye W; Zhang Q; Li X
    Chem Pharm Bull (Tokyo); 2019; 67(5):419-425. PubMed ID: 31061366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Combined Ezetimibe/Atorvastatin Therapy vs. Atorvastatin Monotherapy on the Erythrocyte Membrane Structure in Patients with Coronary Artery Disease: A Pilot Study.
    Jackowska P; Pytel E; Koter-Michalak M; Olszewska-Banaszczyk M; Legęza A; Broncel M
    Adv Clin Exp Med; 2016; 25(3):433-9. PubMed ID: 27629730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of fixed dose combination of atorvastatin and hydroxychloroquine: a randomized, double-blind comparison with atorvastatin alone among Indian patients with dyslipidemia.
    Pareek A; Chandurkar N; Thulaseedharan NK; Legha R; Agarwal M; Mathur SL; Salkar HR; Pednekar S; Pai V; Sriram U; Khyalappa R; Parmar M; Agrawal N; Dhruv U; Saxena S
    Curr Med Res Opin; 2015 Nov; 31(11):2105-17. PubMed ID: 26371518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study).
    Robinson JG; Ballantyne CM; Hsueh W; Rosen J; Lin J; Shah A; Lowe RS; Hanson ME; Tershakovec AM
    J Clin Lipidol; 2011; 5(6):474-82. PubMed ID: 22108151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial.
    Ballantyne CM; Houri J; Notarbartolo A; Melani L; Lipka LJ; Suresh R; Sun S; LeBeaut AP; Sager PT; Veltri EP;
    Circulation; 2003 May; 107(19):2409-15. PubMed ID: 12719279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the effects of low- and high-dose atorvastatin on lipoprotein metabolism and inflammatory cytokines in type 2 diabetes: Results from the Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA) randomized trial.
    Soran H; Liu Y; Adam S; Siahmansur T; Ho JH; Schofield JD; Kwok S; Gittins M; France M; Younis N; Gibson JM; Durrington PN; Rutter MK
    J Clin Lipidol; 2018; 12(1):44-55. PubMed ID: 29246729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of atorvastatin and ezetimibe on endothelial function in dyslipidemic patients with chronic kidney disease.
    Ishimitsu T; Ohno E; Ueno Y; Onoda S; Nagase A; Ohira T; Nakano N; Satonaka H
    Clin Exp Nephrol; 2014 Oct; 18(5):704-10. PubMed ID: 24198051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SGLT2 Inhibitor Dapagliflozin Significantly Improves the Peripheral Microvascular Endothelial Function in Patients with Uncontrolled Type 2 Diabetes Mellitus.
    Sugiyama S; Jinnouchi H; Kurinami N; Hieshima K; Yoshida A; Jinnouchi K; Nishimura H; Suzuki T; Miyamoto F; Kajiwara K; Jinnouchi T
    Intern Med; 2018 Aug; 57(15):2147-2156. PubMed ID: 29607968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consistency of effect of ezetimibe/simvastatin compared with intensified lipid-lowering treatment strategies in obese and non-obese diabetic subjects.
    Rosen JB; Jimenez JG; Pirags V; Vides H; Massaad R; Hanson ME; Brudi P; Triscari J
    Lipids Health Dis; 2013 Jul; 12():103. PubMed ID: 23866306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing the combination therapy of ezetimibe and atorvastatin with atorvastatin monotherapy for regulating blood lipids: a systematic review and meta-analyse.
    Ai C; Zhang S; He Q; Shi J
    Lipids Health Dis; 2018 Oct; 17(1):239. PubMed ID: 30326894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of rosuvastatin monotherapy and atorvastatin-ezetimibe combined therapy on the structure of erythrocyte membranes in patients with coronary artery disease.
    Olszewska-Banaszczyk M; Jackowska P; Gorzelak-Pabiś P; Pytel E; Koter-Michalak M; Broncel M
    Pharmacol Rep; 2018 Apr; 70(2):258-262. PubMed ID: 29475008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.